Literature DB >> 7124768

The randomized controlled clinical trial. Scientific and ethical bases.

D H Spodick.   

Abstract

Randomized controlled trials are increasingly accepted in principle but not always in practice, particularly for surgical therapies. Successful surgical randomized controlled trials demonstrate their feasibility, and reports of uncontrolled surgical trials now commonly bear a statement that a definitive answer requires a controlled trial. Scientifically, the randomized controlled trial is the most powerful way to determine a result ascribable only to the trial treatment. Although randomized controlled trials can be imperfect or improperly conducted, they are designed to circumvent biased behavior by investigators. With candor in informed consent, the equal chance not to get a trial treatment makes the randomized controlled trial the most ethical design. Thus, scientific, behavioral, and ethical cases support the randomized controlled trial as the optimal method for investigation of nearly all therapeutic innovations and as a requirement for publication.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  1982        PMID: 7124768     DOI: 10.1016/0002-9343(82)90746-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Trials and fast changing technologies: the case for tracker studies.

Authors:  R J Lilford; D A Braunholtz; R Greenhalgh; S J Edwards
Journal:  BMJ       Date:  2000-01-01

2.  Radiological progression in rheumatoid arthritis: how many patients are required in a treatment trial to test disease modification?

Authors:  J T Sharp; F Wolfe; M Corbett; H Isomaki; D M Mitchell; D E Furst; J Sibley; M Shipley
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

3.  Brain tumor protocols in North America.

Authors:  M Bernstein; J Rutka
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

4.  Physicians' beliefs and behaviour during a randomized controlled trial of episiotomy: consequences for women in their care.

Authors:  M C Klein; J Kaczorowski; J M Robbins; R J Gauthier; S H Jorgensen; A K Joshi
Journal:  CMAJ       Date:  1995-09-15       Impact factor: 8.262

Review 5.  Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

Authors:  Simone Lanini; Alimuddin Zumla; John P A Ioannidis; Antonino Di Caro; Sanjeev Krishna; Lawrence Gostin; Enrico Girardi; Michel Pletschette; Gino Strada; Aldo Baritussio; Gina Portella; Giovanni Apolone; Silvio Cavuto; Roberto Satolli; Peter Kremsner; Francesco Vairo; Giuseppe Ippolito
Journal:  Lancet Infect Dis       Date:  2015-04-14       Impact factor: 25.071

6.  The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).

Authors:  Clare Moynihan; Rebecca Lewis; Emma Hall; Emma Jones; Alison Birtle; Robert Huddart
Journal:  Trials       Date:  2012-11-29       Impact factor: 2.279

7.  Intestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma.

Authors:  Haiye Jiang; Jian Li; Bin Zhang; Rong Huang; Junhua Zhang; Ziwei Chen; Xueling Shang; Xisheng Li; Xinmin Nie
Journal:  Front Oncol       Date:  2019-12-06       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.